MZE001

Sanofi strikes a $150M deal for Maze’s Pompe disease drug
BioPharma Dive
Mon, 05/1/23 - 10:10 am
Maze Therapeutics
Pompe disease
Sanofi
MZE001
Maze Therapeutics navigates $190M financing round as it plots course to the clinic
Fierce Biotech
Mon, 01/10/22 - 11:45 am
Maze Therapeutics
funding
MZE001
Pompe disease